Literature DB >> 25570693

Assessing instantaneous energy in the EEG: a non-negative, frequency-weighted energy operator.

John M O'Toole, Andriy Temko, Nathan Stevenson.   

Abstract

Signal processing measures of instantaneous energy typically include only amplitude information. But measures that include both amplitude and frequency do better at assessing the energy required by the system to generate the signal, making them more sensitive measures to include in electroencephalogram (EEG) analysis. The Teager-Kaiser operator is a frequency-weighted measure that is frequently used in EEG analysis, although the operator is poorly defined in terms of common signal processing concepts. We propose an alternative frequency-weighted energy measure that uses the envelope of the derivative of the signal. This simple envelope- derivative operator has the advantage of being nonnegative, which when applied to a detection application in newborn EEG improves performance over the Teager-Kaiser operator: without post-processing filters, area-under the receiver-operating characteristic curve (AUC) is 0.57 for the Teager-Kaiser operator and 0.80 for the envelope-derivative operator. The envelope-derivative operator also satisfies important properties, similar to the Teager-Kaiser operator, such as tracking instantaneous amplitude and frequency.

Mesh:

Year:  2014        PMID: 25570693     DOI: 10.1109/EMBC.2014.6944325

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  2 in total

1.  Identifying tracé alternant activity in neonatal EEG using an inter-burst detection approach.

Authors:  Sumit A Raurale; Geraldine B Boylan; Gordon Lightbody; John M O'Toole
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2020-07

2.  Detecting bursts in the EEG of very and extremely premature infants using a multi-feature approach.

Authors:  John M O'Toole; Geraldine B Boylan; Rhodri O Lloyd; Robert M Goulding; Sampsa Vanhatalo; Nathan J Stevenson
Journal:  Med Eng Phys       Date:  2017-04-18       Impact factor: 2.242

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.